The risk of breast cancer following ovarian cancer in women with a pathogenic mutation in BRCA1 or BRCA2
Year: 2026
Type: article
Authors: Adriana I. Apostol, Jacek Gronwald, Cezary Cybulski, Raymond H. Kim, Beth Y. Karlan, Louise Bordeleau, Teresa Ramón Y Cajal, Tuya Pal, Andrea Eisen, Christian F. Singer, Fergus J. Couch, Dana Zakalik, Nadine Tung, Robert Fruscio, William D. Foulkes, Amber Aeilts, Ping Sun, Jan Lubinski, Steven A. Narod, Joanne Kotsopoulos
Institutions: University of Toronto, Agostino Gemelli University Polyclinic, Women’s College Hospital Research and Innovation Institute, International Hereditary Cancer Center, Pomeranian Medical University, University Health Network, Princess Margaret Cancer Centre, University of California, Los Angeles, Juravinski Cancer Centre, McMaster University, Hospital de Sant Pau, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Sunnybrook Health Science Centre, Odette Cancer Centre, Comprehensive Cancer Center Vienna, Medical University of Vienna, Mayo Clinic, Corewell Health William Beaumont University Hospital, Beth Israel Deaconess Medical Center, University of Milano-Bicocca, McGill University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129427055